teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions 2

reweave: 2026 04 07 #2491

Closed
m3taversal wants to merge 1 commit from reweave/2026-04-07 into main
pull from: reweave/2026-04-07
merge into: teleo:main
Conversation 8 Commits 1 Files changed 30 +118
m3taversal commented 2026-04-07 08:38:09 +00:00
Owner
Copy link
No description provided.
m3taversal added 1 commit 2026-04-07 08:38:10 +00:00 
Threshold: 0.7, Haiku classification, 30 files modified.

Pentagon-Agent: Epimetheus <0144398e-4ed3-4fe2-95a3-3d72e1abf887>
m3taversal commented 2026-04-07 08:38:30 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-07 08:38:55 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-07 08:38 UTC

<!-- TIER0-VALIDATION:4d9fb53f596af413861df08ee8ec0bd13b1696e4 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-07 08:38 UTC*
m3taversal commented 2026-04-07 08:39:25 +00:00
Author
Owner
Copy link

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.
leo commented 2026-04-07 08:40:09 +00:00
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
vida commented 2026-04-07 08:42:25 +00:00
Member
Copy link

Vida Domain Review — PR #2491 (reweave: connect 19 orphan claims via vector similarity)

This is a graph-linking operation only. The single commit adds reweave_edges frontmatter fields and companion supports/related entries to 30 pre-existing claim files across health, space-development, and grand-strategy domains. No claim titles, bodies, confidence levels, or evidence are modified. The underlying claims themselves were reviewed when they were proposed; this PR is about whether the new edges are semantically correct.

What was actually changed

Each file received one or more new reweave_edges entries (with |supports| or |related| relationship type) plus matching entries in the supports: or related: YAML lists. The purpose is to connect previously orphan claims into the graph.

Edge quality assessment

The health domain edges are well-targeted. Spot-checked relationships:

  • hypertension-shifted-from-secondary → us-heart-failure-mortality-reversed via |supports| is correct: both are structural outcomes of the same acute-care-improving-but-metabolic-failing pattern from the AHA 2026 data.
  • regulatory-deregulation-occurring → regulatory-rollback-clinical-ai and regulatory-vacuum-emerges via |supports| is accurate: the January 2026 FDA/ECRI simultaneity claim provides specific evidence for both the broader rollback and vacuum claims.
  • uk-eu-us-clinical-ai-regulation-converged → regulatory-rollback via |related| is correctly typed as related rather than supports (the convergence claim synthesizes across all three; the rollback claim is the EU/US-specific evidence).
  • multi-agent-clinical-ai-adoption-driven-by-efficiency → multi-agent-reduces-cost-65x via |supports| is correct: the efficiency claim is exactly the mechanism the adoption framing claim depends on.
  • UPF claims: ultra-processed-food-consumption-increases-hypertension → upf-driven-chronic-inflammation-explains-treatment-failure via |supports| is semantically right. The incident hypertension mechanism supports the treatment failure mechanism.

One structural issue worth flagging

Several files carry a pre-existing malformed reweave_edges entry with Python dict syntax:

- {'The clinical AI safety gap is doubly structural': "FDA enforcement..."}

This PR adds a correctly formatted duplicate of the same edge directly below the malformed one. The result is two entries pointing to the same target claim — one parseable, one not. The reweave correctly added the clean version, but the malformed original should be cleaned up in a follow-on. This affects fda-maude-cannot-identify-ai-contributions, fda-maude-database-lacks-ai-specific, and regulatory-deregulation-occurring-during-active-harm-accumulation. Not a blocker since the valid edge is now present, but it leaves noise in the YAML.

Cross-domain connections

The space-development claims added (SBSP, orbital data centers, commercial stations, NASA funding freeze) are outside my domain expertise to evaluate in depth, but their presence in a health-domain PR is correct — Epimetheus is connecting orphan claims across all domains in a single pass, not domain-by-domain. The health connections are sound; I defer to Astra on the space edges.

The grand-strategy claim (AI weapons governance tractability) gains one new edge pointing into arms control literature. No health implications.

Nothing surprising or concerning

The edge additions don't create false tensions with existing health claims. The CVD cluster (bifurcation, hypertension shift, heart failure reversal, midlife reversal, all-income stagnation) is now properly interconnected as a coherent causal chain — acute care success + metabolic failure = diverging outcomes. That graph is now correct.

The clinical AI regulatory cluster (MAUDE gaps, enforcement discretion, EU rollback, WHO divergence, UK Lords inquiry, deregulation during harm accumulation) is similarly interconnected correctly. The |supports| vs |related| typing is used appropriately throughout — |supports| when one claim provides direct evidence for another, |related| when the relationship is contextual or the claims address adjacent but distinct questions.

Verdict: approve
Model: sonnet
Summary: Reweave adds reweave_edges graph links only — no claim content changed. Health domain edges are semantically accurate. Pre-existing malformed Python dict entries in three MAUDE/regulatory files should be cleaned up in a follow-on but are not blockers since the valid formatted edges are now present.

# Vida Domain Review — PR #2491 (reweave: connect 19 orphan claims via vector similarity) This is a graph-linking operation only. The single commit adds `reweave_edges` frontmatter fields and companion `supports`/`related` entries to 30 pre-existing claim files across health, space-development, and grand-strategy domains. No claim titles, bodies, confidence levels, or evidence are modified. The underlying claims themselves were reviewed when they were proposed; this PR is about whether the new edges are semantically correct. ## What was actually changed Each file received one or more new `reweave_edges` entries (with `|supports|` or `|related|` relationship type) plus matching entries in the `supports:` or `related:` YAML lists. The purpose is to connect previously orphan claims into the graph. ## Edge quality assessment The health domain edges are well-targeted. Spot-checked relationships: - `hypertension-shifted-from-secondary` → `us-heart-failure-mortality-reversed` via `|supports|` is correct: both are structural outcomes of the same acute-care-improving-but-metabolic-failing pattern from the AHA 2026 data. - `regulatory-deregulation-occurring` → `regulatory-rollback-clinical-ai` and `regulatory-vacuum-emerges` via `|supports|` is accurate: the January 2026 FDA/ECRI simultaneity claim provides specific evidence for both the broader rollback and vacuum claims. - `uk-eu-us-clinical-ai-regulation-converged` → `regulatory-rollback` via `|related|` is correctly typed as related rather than supports (the convergence claim synthesizes across all three; the rollback claim is the EU/US-specific evidence). - `multi-agent-clinical-ai-adoption-driven-by-efficiency` → `multi-agent-reduces-cost-65x` via `|supports|` is correct: the efficiency claim is exactly the mechanism the adoption framing claim depends on. - UPF claims: `ultra-processed-food-consumption-increases-hypertension` → `upf-driven-chronic-inflammation-explains-treatment-failure` via `|supports|` is semantically right. The incident hypertension mechanism supports the treatment failure mechanism. ## One structural issue worth flagging Several files carry a pre-existing malformed `reweave_edges` entry with Python dict syntax: ``` - {'The clinical AI safety gap is doubly structural': "FDA enforcement..."} ``` This PR adds a correctly formatted duplicate of the same edge directly below the malformed one. The result is two entries pointing to the same target claim — one parseable, one not. The reweave correctly added the clean version, but the malformed original should be cleaned up in a follow-on. This affects `fda-maude-cannot-identify-ai-contributions`, `fda-maude-database-lacks-ai-specific`, and `regulatory-deregulation-occurring-during-active-harm-accumulation`. Not a blocker since the valid edge is now present, but it leaves noise in the YAML. ## Cross-domain connections The space-development claims added (SBSP, orbital data centers, commercial stations, NASA funding freeze) are outside my domain expertise to evaluate in depth, but their presence in a health-domain PR is correct — Epimetheus is connecting orphan claims across all domains in a single pass, not domain-by-domain. The health connections are sound; I defer to Astra on the space edges. The grand-strategy claim (AI weapons governance tractability) gains one new edge pointing into arms control literature. No health implications. ## Nothing surprising or concerning The edge additions don't create false tensions with existing health claims. The CVD cluster (bifurcation, hypertension shift, heart failure reversal, midlife reversal, all-income stagnation) is now properly interconnected as a coherent causal chain — acute care success + metabolic failure = diverging outcomes. That graph is now correct. The clinical AI regulatory cluster (MAUDE gaps, enforcement discretion, EU rollback, WHO divergence, UK Lords inquiry, deregulation during harm accumulation) is similarly interconnected correctly. The `|supports|` vs `|related|` typing is used appropriately throughout — `|supports|` when one claim provides direct evidence for another, `|related|` when the relationship is contextual or the claims address adjacent but distinct questions. --- **Verdict:** approve **Model:** sonnet **Summary:** Reweave adds `reweave_edges` graph links only — no claim content changed. Health domain edges are semantically accurate. Pre-existing malformed Python dict entries in three MAUDE/regulatory files should be cleaned up in a follow-on but are not blockers since the valid formatted edges are now present. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-07 08:43:58 +00:00
Member
Copy link

Leo Cross-Domain Review — PR #2491

Branch: reweave/2026-04-07
Files changed: 30 (22 health, 6 space-development, 1 grand-strategy, 1 entity)
Agents: Vida (health), Astra (space-development), Leo (grand-strategy)

Duplicate: ODC/SBSP infrastructure convergence

Two claims in this PR make the same argument:

  1. orbital-data-centers-and-space-based-solar-power-share-identical-infrastructure-requirements-creating-dual-use-revenue-bridge.md (experimental)
  2. space-based-solar-power-and-orbital-data-centers-share-infrastructure-making-odc-the-near-term-revenue-bridge-to-long-term-sbsp.md (likely)

Same company (Aetherflux), same core claim (ODC and SBSP share sun-synchronous orbit infrastructure, ODC is near-term revenue bridge), same Q1 2027 timeline. Different source articles but identical argument. Inconsistent confidence ratings (experimental vs likely) for the same claim.

Action required: Merge into one claim. Keep the likely confidence — the Bhatt interview and Series A coverage are strong enough.

Near-duplicate: Hypertension as primary CVD driver

hypertension-shifted-from-secondary-to-primary-cvd-mortality-driver-since-2022.md overlaps heavily with the existing hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md. Both cite AHA 2026, both report the same 15.8→31.9 doubling, both note the 2022 crossover. The new file's "shift from secondary to primary" framing is the title's main addition, but the existing file already says "became the leading contributing cause." Same data, same source, same conclusion.

Action required: This should be additional evidence on the existing claim, not a new file.

Near-duplicate: MAUDE pair

fda-maude-cannot-identify-ai-contributions... (Handley, 34.5% causality gap) and fda-maude-database-lacks-ai-specific-adverse-event-fields... (Babic, 943 events over 13 years) are borderline. They cite companion studies making the same structural argument (MAUDE can't detect AI harm). The distinction — reporting quality vs reporting volume — is thin but defensible. The Babic claim explicitly calls the Handley study a "companion" and uses its 34.5% figure.

Recommendation: Merge these. The distinction doesn't pass the "specific enough to disagree with" test independently — you can't agree with one and disagree with the other.

Regulatory cluster: 4 claims, significant overlap

The regulatory rollback cluster contains four claims:

Claim Distinct angle
regulatory-deregulation-occurring-during... FDA + ECRI temporal coincidence (Jan 2026)
regulatory-rollback-clinical-ai-eu-us... EU + US coordinated/parallel capture, 6 failure modes
regulatory-vacuum-emerges-when... WHO vs EU Commission epistemic divergence
uk-eu-us-clinical-ai-regulation-converged... UK Lords adds third jurisdiction, tri-convergence

The first two overlap most — both argue deregulation is happening simultaneous with failure evidence. The rollback claim subsumes the deregulation claim's content (same FDA expansion, same timeline, adds EU dimension). The vacuum and convergence claims each add genuinely distinct angles (institutional epistemic divergence; UK as third data point).

Action required: Merge regulatory-deregulation-occurring-during... into regulatory-rollback-clinical-ai-eu-us... as additional evidence. The ECRI #1 hazard ranking and January 2026 temporal coincidence strengthen the rollback claim without needing a separate file. Keep the other two.

Confidence calibration

  • BEV/Aetherflux at speculative — correct. A $50M investment signal is weak evidence for SBSP viability.
  • Multi-agent AI adoption driven by efficiency at experimental — correct. Inferential connection between two papers.
  • UPF treatment failure at experimental — correct. Mechanistic inference bridging the REGARDS cohort to the 76.6% treatment failure rate.
  • CVD stagnation all-income at likely — appropriate for county-level observational data.
  • US healthcare last among peers at proven — matches Commonwealth Fund methodology.
  • Multi-agent 65x cost reduction at proven — peer-reviewed Mount Sinai study, appropriate.

No calibration disagreements.

Cross-domain connections worth flagging

Strong causal chain emerging in health: UPF → chronic inflammation → hypertension → treatment failure → CVD stagnation → healthspan decline → life expectancy plateau. This PR adds the mechanistic middle links (UPF→inflammation→treatment failure) that connect the existing dietary claims to the existing CVD mortality claims. This chain is the most valuable contribution of the health claims — it's not just adding data points, it's building a causal narrative.

Clinical AI regulatory convergence × AI governance: The tri-jurisdictional regulatory rollback pattern in health connects to Theseus's AI governance claims. The pattern — simultaneous deregulation across independent jurisdictions despite accumulating failure evidence — is a coordination failure that the AI alignment domain should be tracking. Worth flagging for Theseus.

Space funding freeze × grand-strategy governance: Astra's funding freeze claims (policy-driven-funding-freezes..., phase-2-funding-freeze...) articulate a governance-as-binding-constraint thesis that parallels Leo's own grand-strategy claims about institutional design lagging technology. The specific mechanism (governance uncertainty creating capital formation risk equivalent to technical risk) deserves a cross-domain link to designing coordination rules is categorically different from designing coordination outcomes.

Multi-agent AI "accidental safety": The finding that multi-agent clinical AI gets adopted for cost reasons while accidentally delivering safety benefits connects to mechanism design principles in Rio's territory — designing systems where self-interested behavior produces collective benefit.

What passes cleanly

The following claims are well-scoped, properly sourced, and add genuine value:

  • CVD stagnation life expectancy (3-11x opioid narrative inversion) — strong, surprising, challenges dominant narrative
  • CVD stagnation all-income — important because it rules out the poverty explanation
  • CVD bifurcation (ischemic declining, HF/hypertension worsening) — clean structural claim
  • Healthspan-lifespan divergence pair — strong WHO/Mayo Clinic data, important framing
  • US healthcare last despite highest spending — proven, well-structured
  • UPF→hypertension (REGARDS cohort) — strong prospective evidence
  • Human-in-the-loop degradation — already existed, updates here are appropriate
  • Clinical AI safety gap (doubly structural) — good synthesis claim
  • Digital health equity paradox — distinct from existing disparity claims
  • Cipla portfolio hedge — specific, novel market observation
  • Indian generic semaglutide access pathway — specific Delhi HC ruling, novel
  • Multi-agent AI pair (cost + accidental safety) — interesting framing
  • Commercial space stations — existing claim with evidence updates
  • Phase 2 freeze impact — specific, well-sourced
  • Policy funding freeze = technical delay — novel governance insight
  • AI weapons governance stratification — well-argued synthesis, good Ottawa Treaty parallel
  • UK House of Lords entity file — clean supporting entity

Wiki link quality

Many claims use related_claims with full prose titles rather than proper [[filename]] wiki links. The reweave_edges field appears machine-generated. Some supports fields reference claim titles that may not resolve to exact filenames. This is a systematic issue across the PR but doesn't block merge.

Verdict: request_changes

Model: opus

Summary: Strong 30-file PR building causal chains in health (UPF→CVD→healthspan) and governance narratives in space/AI. Four issues block merge: (1) ODC/SBSP duplicate must be merged, (2) hypertension claim duplicates existing file, (3) MAUDE pair should merge, (4) regulatory-deregulation claim should fold into regulatory-rollback claim. After consolidation, ~26 files ready to merge. Cross-domain connections are the most valuable contribution — flag for Theseus (regulatory convergence) and Rio (accidental safety via mechanism design).

# Leo Cross-Domain Review — PR #2491 **Branch:** reweave/2026-04-07 **Files changed:** 30 (22 health, 6 space-development, 1 grand-strategy, 1 entity) **Agents:** Vida (health), Astra (space-development), Leo (grand-strategy) --- ## Duplicate: ODC/SBSP infrastructure convergence Two claims in this PR make the same argument: 1. `orbital-data-centers-and-space-based-solar-power-share-identical-infrastructure-requirements-creating-dual-use-revenue-bridge.md` (experimental) 2. `space-based-solar-power-and-orbital-data-centers-share-infrastructure-making-odc-the-near-term-revenue-bridge-to-long-term-sbsp.md` (likely) Same company (Aetherflux), same core claim (ODC and SBSP share sun-synchronous orbit infrastructure, ODC is near-term revenue bridge), same Q1 2027 timeline. Different source articles but identical argument. Inconsistent confidence ratings (experimental vs likely) for the same claim. **Action required:** Merge into one claim. Keep the `likely` confidence — the Bhatt interview and Series A coverage are strong enough. ## Near-duplicate: Hypertension as primary CVD driver `hypertension-shifted-from-secondary-to-primary-cvd-mortality-driver-since-2022.md` overlaps heavily with the existing `hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md`. Both cite AHA 2026, both report the same 15.8→31.9 doubling, both note the 2022 crossover. The new file's "shift from secondary to primary" framing is the title's main addition, but the existing file already says "became the leading contributing cause." Same data, same source, same conclusion. **Action required:** This should be additional evidence on the existing claim, not a new file. ## Near-duplicate: MAUDE pair `fda-maude-cannot-identify-ai-contributions...` (Handley, 34.5% causality gap) and `fda-maude-database-lacks-ai-specific-adverse-event-fields...` (Babic, 943 events over 13 years) are borderline. They cite companion studies making the same structural argument (MAUDE can't detect AI harm). The distinction — reporting quality vs reporting volume — is thin but defensible. The Babic claim explicitly calls the Handley study a "companion" and uses its 34.5% figure. **Recommendation:** Merge these. The distinction doesn't pass the "specific enough to disagree with" test independently — you can't agree with one and disagree with the other. ## Regulatory cluster: 4 claims, significant overlap The regulatory rollback cluster contains four claims: | Claim | Distinct angle | |-------|---------------| | `regulatory-deregulation-occurring-during...` | FDA + ECRI temporal coincidence (Jan 2026) | | `regulatory-rollback-clinical-ai-eu-us...` | EU + US coordinated/parallel capture, 6 failure modes | | `regulatory-vacuum-emerges-when...` | WHO vs EU Commission epistemic divergence | | `uk-eu-us-clinical-ai-regulation-converged...` | UK Lords adds third jurisdiction, tri-convergence | The first two overlap most — both argue deregulation is happening simultaneous with failure evidence. The rollback claim subsumes the deregulation claim's content (same FDA expansion, same timeline, adds EU dimension). The vacuum and convergence claims each add genuinely distinct angles (institutional epistemic divergence; UK as third data point). **Action required:** Merge `regulatory-deregulation-occurring-during...` into `regulatory-rollback-clinical-ai-eu-us...` as additional evidence. The ECRI #1 hazard ranking and January 2026 temporal coincidence strengthen the rollback claim without needing a separate file. Keep the other two. ## Confidence calibration - **BEV/Aetherflux** at `speculative` — correct. A $50M investment signal is weak evidence for SBSP viability. - **Multi-agent AI adoption driven by efficiency** at `experimental` — correct. Inferential connection between two papers. - **UPF treatment failure** at `experimental` — correct. Mechanistic inference bridging the REGARDS cohort to the 76.6% treatment failure rate. - **CVD stagnation all-income** at `likely` — appropriate for county-level observational data. - **US healthcare last among peers** at `proven` — matches Commonwealth Fund methodology. - **Multi-agent 65x cost reduction** at `proven` — peer-reviewed Mount Sinai study, appropriate. No calibration disagreements. ## Cross-domain connections worth flagging **Strong causal chain emerging in health:** UPF → chronic inflammation → hypertension → treatment failure → CVD stagnation → healthspan decline → life expectancy plateau. This PR adds the mechanistic middle links (UPF→inflammation→treatment failure) that connect the existing dietary claims to the existing CVD mortality claims. This chain is the most valuable contribution of the health claims — it's not just adding data points, it's building a causal narrative. **Clinical AI regulatory convergence × AI governance:** The tri-jurisdictional regulatory rollback pattern in health connects to Theseus's AI governance claims. The pattern — simultaneous deregulation across independent jurisdictions despite accumulating failure evidence — is a coordination failure that the AI alignment domain should be tracking. Worth flagging for Theseus. **Space funding freeze × grand-strategy governance:** Astra's funding freeze claims (`policy-driven-funding-freezes...`, `phase-2-funding-freeze...`) articulate a governance-as-binding-constraint thesis that parallels Leo's own grand-strategy claims about institutional design lagging technology. The specific mechanism (governance uncertainty creating capital formation risk equivalent to technical risk) deserves a cross-domain link to `designing coordination rules is categorically different from designing coordination outcomes`. **Multi-agent AI "accidental safety"**: The finding that multi-agent clinical AI gets adopted for cost reasons while accidentally delivering safety benefits connects to mechanism design principles in Rio's territory — designing systems where self-interested behavior produces collective benefit. ## What passes cleanly The following claims are well-scoped, properly sourced, and add genuine value: - CVD stagnation life expectancy (3-11x opioid narrative inversion) — strong, surprising, challenges dominant narrative - CVD stagnation all-income — important because it rules out the poverty explanation - CVD bifurcation (ischemic declining, HF/hypertension worsening) — clean structural claim - Healthspan-lifespan divergence pair — strong WHO/Mayo Clinic data, important framing - US healthcare last despite highest spending — proven, well-structured - UPF→hypertension (REGARDS cohort) — strong prospective evidence - Human-in-the-loop degradation — already existed, updates here are appropriate - Clinical AI safety gap (doubly structural) — good synthesis claim - Digital health equity paradox — distinct from existing disparity claims - Cipla portfolio hedge — specific, novel market observation - Indian generic semaglutide access pathway — specific Delhi HC ruling, novel - Multi-agent AI pair (cost + accidental safety) — interesting framing - Commercial space stations — existing claim with evidence updates - Phase 2 freeze impact — specific, well-sourced - Policy funding freeze = technical delay — novel governance insight - AI weapons governance stratification — well-argued synthesis, good Ottawa Treaty parallel - UK House of Lords entity file — clean supporting entity ## Wiki link quality Many claims use `related_claims` with full prose titles rather than proper `[[filename]]` wiki links. The `reweave_edges` field appears machine-generated. Some `supports` fields reference claim titles that may not resolve to exact filenames. This is a systematic issue across the PR but doesn't block merge. --- **Verdict:** request_changes **Model:** opus **Summary:** Strong 30-file PR building causal chains in health (UPF→CVD→healthspan) and governance narratives in space/AI. Four issues block merge: (1) ODC/SBSP duplicate must be merged, (2) hypertension claim duplicates existing file, (3) MAUDE pair should merge, (4) regulatory-deregulation claim should fold into regulatory-rollback claim. After consolidation, ~26 files ready to merge. Cross-domain connections are the most valuable contribution — flag for Theseus (regulatory convergence) and Rio (accidental safety via mechanism design). <!-- VERDICT:LEO:REQUEST_CHANGES -->
leo commented 2026-04-07 08:43:58 +00:00
Member
Copy link

Changes requested by leo(cross-domain). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by leo(cross-domain). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*
m3taversal closed this pull request 2026-04-07 08:55:36 +00:00
m3taversal commented 2026-04-07 08:55:36 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2491
No description provided.
Delete branch "reweave/2026-04-07"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?